You are here: All Products  > Simcere Acquires Commercialization Rights to Mabpharm’s Colorectal Cancer Therapy

Simcere Acquires Commercialization Rights to Mabpharm’s Colorectal Cancer Therapy

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products